Pharmaceutical ETF Investing: Comparing VanEck and State Street SPDR
Pharmaceutical ETF investing: two approaches
VanEck’s pharmaceutical ETF and State Street SPDR’s pharmaceutical ETF take different approaches to investing in the sector. The supplied information reports that VanEck’s concentrated, 26-stock portfolio delivered stronger five-year returns and lower volatility. State Street SPDR holds 62 stocks, offering broader diversification and lower fees.
Key differences for investors
- VanEck: A concentrated portfolio with 26 stock holdings and stronger reported five-year returns.
- State Street SPDR: A broader portfolio with 62 holdings and lower reported fees.
- Volatility: The provided comparison says VanEck had lower volatility over the five-year period.
What to review before investing
Past performance does not guarantee future results. Before choosing a fund, investors can check current fees, holdings, performance periods, and stock valuation, then compare those details with their portfolio goals and risk tolerance. This comparison is a starting point for stock research, not individualized financial advice.
For current figures and additional financial information, consult the funds’ official materials and the original source.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.